Soo-Ho Ban

Title: The Innovative Contributions of Soo-Ho Ban

Introduction

Soo-Ho Ban is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of cancer research through his innovative work on cyclin-dependent kinase inhibitors. His research focuses on developing compounds that can effectively combat various types of cancer.

Latest Patents

Soo-Ho Ban holds a patent for "Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors." This invention relates to an indirubin-3'-oxime derivative that exhibits potent cyclin-dependent kinase inhibition with anti-cancer activity. More specifically, the invention demonstrates excellent anti-cancer activity against human lung cancer cells, human fibro sarcoma cells, human colon cancer cells, human leukemia cells, human stomach cancer cells, human nasopharyngeal cancer cells, and human breast cancer cells. He has 1 patent to his name.

Career Highlights

Soo-Ho Ban is associated with Anygen Co., Ltd., where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential impact on cancer treatment and patient outcomes.

Collaborations

Soo-Ho Ban collaborates with talented individuals in his field, including Yong-Chul Kim and Jae-Il Kim. These partnerships enhance the research and development of innovative cancer therapies.

Conclusion

Soo-Ho Ban's contributions to cancer research through his innovative inventions highlight the importance of scientific advancements in the fight against cancer. His work continues to inspire future research and development in this critical area of medicine.